Venetoclax Plus Daratumumab Bridging Allo-HSCT in Early T-Cell Precursor Acute Lymphoblastic Leukemia

被引：0
|
作者：
Meng, Fanqiao [1 ,2 ]
Liu, Yu [1 ,2 ]
Zeng, Dongfeng [1 ,2 ]
机构：
[1] Army Med Univ, Third Mil Med Univ, Daping Hosp, Dept Hematol, Chongqing, Peoples R China
[2] Chongqing Key Lab Hematol & Microenvironm, Chongqing, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2025年
关键词：
D O I：
10.1002/pbc.31679
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Quartic CAR-T Cell Bridging to Twice Allo-HSCT Therapy in a Patient with Acute Lymphoblastic Leukemia
    Zhang, Qing
    Dong, Yi
    Zhai, Zhimin
    Tao, Qianshan
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2024, 51 (01) : 55 - 60
  • [2] CAR T-cell bridging to allo-HSCT for relapsed/refractory B-cell acute lymphoblastic leukemia:the follow-up outcomes
    闫梦
    ChinaMedicalAbstracts(InternalMedicine), 2020, 37 (04) : 234 - 234
  • [3] Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen
    Zhang, Xiang
    Li, Jianhu
    Jin, Jie
    Yu, Wenjuan
    ANNALS OF HEMATOLOGY, 2020, 99 (02) : 395 - 397
  • [4] Relapsed/refractory early T-cell precursor acute lymphoblastic leukemia was salvaged by venetoclax plus HAG regimen
    Xiang Zhang
    Jianhu Li
    Jie Jin
    Wenjuan Yu
    Annals of Hematology, 2020, 99 : 395 - 397
  • [5] Synergistic Effect of Venetoclax and Bendamustine in Early T-cell Precursor Acute Lymphoblastic Leukemia
    Nguyen, Hong Duc Thi
    Le, Tan Minh
    Lee, Donghyeon
    Cho, Hee Jeong
    Lee, Jungmin
    Sohn, Sang Kyun
    Kim, Jong Gwang
    Ham, Ji Yeon
    Moon, Joon Ho
    Han, Hyung Soo
    Kim, Juhyung
    Baek, Dong Won
    IN VIVO, 2024, 38 (04): : 1740 - 1749
  • [6] Venetoclax with chemotherapy in relapse/refractory early T-cell precursor acute lymphoblastic leukemia
    Arora, Sankalp
    Vachhani, Pankit
    Bachiashvili, Kimo
    Jamy, Omer
    LEUKEMIA & LYMPHOMA, 2021, 62 (09) : 2292 - 2294
  • [7] Venetoclax use in a patient with ataxia telangiectasia and early T-cell precursor acute lymphoblastic leukemia
    Alqahtani, Shaikha
    Ramakrishnan, Ramya
    E, Shuyu
    Wang, Sa A.
    Nunez, Cesar
    McCall, David
    Garcia, Miriam B.
    Roth, Michael E.
    Cuglievan, Branko
    Gibson, Amber
    PEDIATRIC BLOOD & CANCER, 2024, 71 (08)
  • [8] First Report of Clinical Response to Venetoclax in Early T-Cell Precursor Acute Lymphoblastic Leukemia
    Numan, Yazan
    Alfayez, Mansour
    Maiti, Abhishek
    Alvarado, Yesid
    Jabbour, Elias J.
    Ferrajoli, Alessandra
    Konoplev, Sergej N.
    Kantarjian, Hagop M.
    Bose, Prithviraj
    JCO PRECISION ONCOLOGY, 2018, 2 : 1 - 6
  • [9] Venetoclax with CAG regimen for early T-cell precursor acute lymphoblastic leukemia: a case report and literature review
    Zhao, Yihan
    Jiang, Shiqing
    Tang, Yujun
    Zhao, Lin
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (04) : 483 - 488
  • [10] Venetoclax and decitabine in refractory TP53-mutated early T-cell precursor acute lymphoblastic leukemia
    Kong, Jinyu
    Chen, Nan
    Li, Mengyun
    Zhang, Jian
    Wu, Xiaoxia
    Zong, Lihong
    Wu, Depei
    Song, Baoquan
    Qiu, Huiying
    ANNALS OF HEMATOLOGY, 2022, 101 (03) : 697 - 699
12345